A detailed history of Obermeyer Wood Investment Counsel, Lllp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Obermeyer Wood Investment Counsel, Lllp holds 10,187 shares of BMY stock, worth $593,189. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,187
Previous 10,437 2.4%
Holding current value
$593,189
Previous $433,000 21.71%
% of portfolio
0.03%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$39.66 - $51.75 $9,915 - $12,937
-250 Reduced 2.4%
10,187 $527,000
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $24,150 - $31,794
-600 Reduced 5.44%
10,437 $433,000
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $7,101 - $8,051
-148 Reduced 1.32%
11,037 $598,000
Q4 2023

Jan 31, 2024

BUY
$48.48 - $57.85 $21,816 - $26,032
450 Added 4.19%
11,185 $573,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $22,229 - $24,856
384 Added 3.71%
10,735 $623,000
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $13,697 - $15,209
-215 Reduced 2.03%
10,351 $661,000
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $501,695 - $569,036
-7,635 Reduced 41.95%
10,566 $732,000
Q3 2022

Dec 09, 2022

BUY
$0.13 - $76.84 $726 - $429,689
5,592 Added 44.35%
18,201 $1.29 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $61,480 - $73,720
1,000 Added 8.61%
12,609 $921,000
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $109,566 - $127,728
-2,043 Reduced 14.96%
11,609 $724,000
Q3 2021

Oct 19, 2021

SELL
$59.17 - $69.31 $124,730 - $146,105
-2,108 Reduced 13.38%
13,652 $808,000
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $73,239 - $79,757
-1,183 Reduced 6.98%
15,760 $1.05 Million
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $520,708 - $585,643
-8,775 Reduced 34.12%
16,943 $1.07 Million
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $98,158 - $111,231
-1,700 Reduced 6.2%
25,718 $1.6 Million
Q3 2020

Oct 22, 2020

SELL
$57.43 - $63.64 $322,469 - $357,338
-5,615 Reduced 17.0%
27,418 $1.65 Million
Q2 2020

Jul 20, 2020

SELL
$54.82 - $64.09 $19,844 - $23,200
-362 Reduced 1.08%
33,033 $1.94 Million
Q1 2020

Apr 30, 2020

SELL
$46.4 - $67.43 $222,952 - $324,001
-4,805 Reduced 12.58%
33,395 $1.86 Million
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $1.31 Million - $1.71 Million
26,687 Added 231.8%
38,200 $2.45 Million
Q3 2019

Nov 06, 2019

SELL
$42.77 - $50.71 $174,800 - $207,251
-4,087 Reduced 26.2%
11,513 $584,000
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $15,617 - $17,269
-350 Reduced 2.19%
15,600 $707,000
Q1 2019

May 03, 2019

SELL
$45.12 - $53.8 $44,984 - $53,638
-997 Reduced 5.88%
15,950 $761,000
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $36,570 - $47,422
-750 Reduced 4.24%
16,947 $881,000
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $38,798 - $43,761
-703 Reduced 3.82%
17,697 $1.1 Million
Q2 2018

Aug 08, 2018

SELL
$50.53 - $62.98 $54,521 - $67,955
-1,079 Reduced 5.54%
18,400 $1.02 Million
Q1 2018

May 07, 2018

SELL
$59.92 - $68.98 $53,388 - $61,461
-891 Reduced 4.37%
19,479 $1.23 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $33,026 - $36,007
551 Added 2.78%
20,370 $1.25 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $1.09 Million - $1.26 Million
19,819
19,819 $1.26 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Obermeyer Wood Investment Counsel, Lllp Portfolio

Follow Obermeyer Wood Investment Counsel, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Obermeyer Wood Investment Counsel, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Obermeyer Wood Investment Counsel, Lllp with notifications on news.